Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies (C5ITs)
Status: Recruiting
Location: See all (40) locations...
Study Type: Observational
SUMMARY
Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Participants with a diagnosis of gMG who are treated with Alexion C5IT at the time of enrollment, including patients previously treated with Soliris or Ultomiris and withdrawn from treatment.
• Capable of giving signed informed consent, which includes compliance with the protocol requirements and restrictions.
• Participants must have myasthenia gravis historical data, such as MG-ADL and MGFA class, available to be enrolled in the Registry.
Locations
United States
Alabama
Clinical Trial Site
RECRUITING
Birmingham
Arizona
Clinical Trial Site
RECRUITING
Scottsdale
California
Clinical Trial Site
RECRUITING
Fresno
Clinical Trial Site
RECRUITING
Orange
Clinical Trial Site
RECRUITING
Rancho Mirage
Clinical Trial Site
RECRUITING
Sylmar
Colorado
Clinical Trial Site
RECRUITING
Colorado Springs
Clinical Trial Site
RECRUITING
Fort Collins
Connecticut
Clinical Trial Site
RECRUITING
New Haven
Washington, D.c.
Clinical Trial Site
RECRUITING
Washington D.c.
Florida
Clinical Trial Site
RECRUITING
Clearwater
Clincal Trial Site
RECRUITING
Gainesville
Clinical Trial Site
RECRUITING
Jacksonville
Clinical Trial Site
RECRUITING
Tampa
Georgia
Clinical Trial Site
RECRUITING
Augusta
Iowa
Clinical Trial Site
RECRUITING
Iowa City
Kentucky
Clinical Trial Site
RECRUITING
Lexington
Massachusetts
Clinical Trial Site
RECRUITING
Boston
Michigan
Clinical Trial Site
RECRUITING
Lansing
Missouri
Clinical Trial Site
RECRUITING
Columbia
North Carolina
Clinical Trial Site
RECRUITING
Chapel Hill
Clinical Trial Site
RECRUITING
Charlotte
Clinical Trial Site
RECRUITING
Durham
New York
Clinical Trial Site
RECRUITING
New Hyde Park
Ohio
Clinical Trial Site
RECRUITING
Dayton
Pennsylvania
Clinical Trial Site
RECRUITING
Philadelphia
Tennessee
Clinical Trial Site
RECRUITING
Chattanooga
Clinical Trial Site
RECRUITING
Knoxville
Texas
Clinical Trial Site
RECRUITING
Dallas
Clinical Trial Site
RECRUITING
Houston
Vermont
Clinical Trial Site
RECRUITING
Burlington
Wisconsin
Clinical Trial Site
RECRUITING
Milwaukee
Other Locations
Austria
Clinical Trial Site
RECRUITING
Vienna
Canada
Clinical Trial Site
RECRUITING
Brampton
Clinical Trial Site
RECRUITING
London
Clinical Trial Site
RECRUITING
Montreal
China
Clinical Trial Site
RECRUITING
Chengdu
Germany
Clinical Trial Site
RECRUITING
Hanover
Italy
Clinical Trial Site
RECRUITING
Milan
Clinical Trial Site
RECRUITING
Naples
Contact Information
Primary
Alexion Pharmaceuticals, Inc. (Sponsor)
clinicaltrials@alexion.com
1-855-752-2356
Time Frame
Start Date: 2019-12-02
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: Alexion Pharmaceuticals, Inc.